CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to AXSM

Phase 3

Development Phase

1

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
Dec '26
AXSMPhase 3

Solriamfetol 300 mg Phase 3 Est. Readout

Solriamfetol 300 mg
Dec 2026~
CT.gov
00%
Competitive Landscape

1 competitor in Binge-Eating Disorder

View Full Landscape
Drug Information

Target Indication

Binge-Eating Disorder

Clinical Trial

NCT06413433

Last updated: 12/4/2025

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.